
USFDA APPLICATION NUMBER - 205103 / DOSAGE - TABLET, DELAYED RELEASE;ORAL - 325MG;40MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| aspirin(UNII: R16CO5Y76E) (aspirin - UNII:R16CO5Y76E) | aspirin | 81mg | 325mg |
| omeprazole(UNII: KG60484QX9) (omeprazole - UNII:KG60484QX9) | omeprazole | 40mg | 40mg |
Inactive Ingredients
| Ingredient Name | Innovida Phamaceutique Corporation |
|---|---|
| carnauba wax(R12CBM0EIZ) | |
| FD&C blue no. 2(L06K8R7DQK) | |
| ferric oxide yellow(EX438O2MRT) | |
| glyceryl monostearate(230OU9XXE4) | |
| HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) | |
| methacrylic acid - ethyl acrylate copolymer (1:1) type A(NX76LV5T8J) | |
| MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | |
| polydextrose(VH2XOU12IE) | |
| POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A) | |
| polysorbate 80(6OZP39ZG8H) | |
| POVIDONE, UNSPECIFIED(FZ989GH94E) | |
| SILICON DIOXIDE(ETJ7Z6XBU4) | |
| sodium phosphate, dibasic, anhydrous(22ADO53M6F) | |
| STARCH, CORN(O8232NY3SJ) | |
| stearic acid(4ELV7Z65AP) | |
| talc(7SEV7J4R1U) | |
| titanium dioxide(15FIX9V2JP) | |
| triacetin(XHX3C3X673) | |
| triethyl citrate(8Z96QXD6UM) |